1. Home
  2. NKTR vs FRAF Comparison

NKTR vs FRAF Comparison

Compare NKTR & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • FRAF
  • Stock Information
  • Founded
  • NKTR 1990
  • FRAF 1906
  • Country
  • NKTR United States
  • FRAF United States
  • Employees
  • NKTR N/A
  • FRAF N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • FRAF Major Banks
  • Sector
  • NKTR Health Care
  • FRAF Finance
  • Exchange
  • NKTR Nasdaq
  • FRAF Nasdaq
  • Market Cap
  • NKTR 160.4M
  • FRAF 173.6M
  • IPO Year
  • NKTR 1994
  • FRAF N/A
  • Fundamental
  • Price
  • NKTR $0.72
  • FRAF $38.40
  • Analyst Decision
  • NKTR Strong Buy
  • FRAF
  • Analyst Count
  • NKTR 6
  • FRAF 0
  • Target Price
  • NKTR $4.92
  • FRAF N/A
  • AVG Volume (30 Days)
  • NKTR 1.9M
  • FRAF 14.3K
  • Earning Date
  • NKTR 05-08-2025
  • FRAF 07-22-2025
  • Dividend Yield
  • NKTR N/A
  • FRAF 3.44%
  • EPS Growth
  • NKTR N/A
  • FRAF N/A
  • EPS
  • NKTR N/A
  • FRAF 2.62
  • Revenue
  • NKTR $87,248,000.00
  • FRAF $71,310,000.00
  • Revenue This Year
  • NKTR N/A
  • FRAF N/A
  • Revenue Next Year
  • NKTR N/A
  • FRAF N/A
  • P/E Ratio
  • NKTR N/A
  • FRAF $14.64
  • Revenue Growth
  • NKTR N/A
  • FRAF 5.61
  • 52 Week Low
  • NKTR $0.43
  • FRAF $26.00
  • 52 Week High
  • NKTR $1.52
  • FRAF $40.76
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 54.57
  • FRAF 50.77
  • Support Level
  • NKTR $0.61
  • FRAF $38.60
  • Resistance Level
  • NKTR $0.74
  • FRAF $39.42
  • Average True Range (ATR)
  • NKTR 0.06
  • FRAF 0.44
  • MACD
  • NKTR 0.01
  • FRAF -0.15
  • Stochastic Oscillator
  • NKTR 81.79
  • FRAF 8.70

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

Share on Social Networks: